Fine-Tuning the Antimicrobial Profile of Biocompatible Gold Nanoparticles by Sequential Surface Functionalization Using Polyoxometalates and Lysine

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Daima, Hemant K ^a   Selvakannan, P R ^a   Shukla, Ravi ^a   Bhargava, Suresh K ^a   Bansal, Vipul ^a  

^a RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD NANOPARTICLE; LYSINE; POLYMER; POLYOXOMETALATE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CHEMICAL ANALYSIS; CHEMICAL INTERACTION; COMPOSITE MATERIAL; CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LUNG CARCINOMA; MATERIAL COATING; MATERIALS TESTING; NANOANALYSIS; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; SURFACE PROPERTY; TOXICITY TESTING; VALIDATION PROCESS;

ANIMALS; ANTI-BACTERIAL AGENTS; GOLD; LYSINE; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; TUNGSTEN COMPOUNDS;

EID: 84885810782     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079676     Document Type: Article

References (42)

1. Leeb M, (2004) Antibiotics: A shot in the arm. Nature 431: 892-893. doi:10.1038/431892a. PubMed: 15496888.
2. Norrby SR, Nord CE, Finch R, (2005) Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect Dis 5: 115-119. doi:10.1016/S1473-3099(05)70086-4. PubMed: 15680781.
3. Amin RM, Mohamed MB, Ramadan MA, Verwanger T, Krammer B, (2009) Rapid and sensitive microplate assay for screening the effect of silver and gold nanoparticles on bacteria. Nanomedicine 4: 637-643. doi:10.2217/nnm.09.50. PubMed: 19663592.
4. Lok CN, Ho CM, Chen R, He QY, Yu WY, et al. (2007) Silver nanoparticles: Partial oxidation and antibacterial activities. J Biol Inorg Chem JBIC Publ Society Of Biological Inorganic Chemistry 12: 527-534. doi:10.1007/s00775-007-0208-z. PubMed: 17353996.
5. Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, et al. (2010) Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 85: 1115-1122. doi:10.1007/s00253-009-2159-5. PubMed: 19669753.
6. Lemire JA, Harrison JJ, Turner RJ, (2013) Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol 11: 371-384. doi:10.1038/nrmicro3028. PubMed: 23669886.
7. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, et al. (2005) Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: A microscopic overview. Langmuir 21: 10644-10654. doi:10.1021/la0513712. PubMed: 16262332.
8. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD, (2005) Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity. Small 1: 325-327. doi:10.1002/smll.200400093. PubMed: 17193451.
9. Panacek A, Kvítek L, Prucek R, Kolar M, Vecerova R, et al. (2006) Silver colloid nanoparticles: Synthesis, characterization, and their antibacterial activity. J Phys Chem B 110: 16248-16253. doi:10.1021/jp063826h. PubMed: 16913750.
10. Martinez-Castanon GA, Nino-Martinez N, Martinez-Gutierrez F, Martinez-Mendoza JR, Ruiz F, (2008) Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res 10: 1343-1348. doi:10.1007/s11051-008-9428-6.
11. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, et al. (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16: 2346-2353. doi:10.1088/0957-4484/16/10/059. PubMed: 20818017.
12. Pal S, Tak YK, Song JM, (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73: 1712-1720. doi:10.1128/AEM.02218-06. PubMed: 17261510.
13. Wiesner MR, Lowry GV, Alvarez P, Dionysiou D, Biswas P, (2006) Assessing the risks of manufactured nanomaterials. Environ Sci Technol 40: 4336-4345. doi:10.1021/es062726m. PubMed: 16903268.
14. Sapsford KE, Algar WR, Berti L, Gemmill KB, Casey BJ, et al. (2013) Functionalizing Nanoparticles with Biological Molecules: Developing Chemistries that Facilitate Nanotechnology. Chem Rev 113: 1904-2074. doi:10.1021/cr300143v. PubMed: 23432378.
15. Daima HK, Periasamy S, Kandjani AE, Shukla R, Bhargava SK, et al. (2013) Synergistic influence of polyoxometalate surface corona towards enhancing the antibacterial performance of tyrosine-capped Ag nanoparticles. Nanoscale. doi:10.1039/C3NR03806H.
16. Hung A, Mager M, Hembury M, Stellacci F, Stevens MM, et al. (2013) Amphiphilic amino acids: a key to adsorbing proteins to nanopatterned surfaces? Chemical. Science 4: 928-937.
17. Goodman CM, McCusker CD, Yilmaz T, Rotello VM, (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15: 897--900. doi:10.1021/bc049951i. PubMed: 15264879.
18. Radovic-Moreno AF, Lu TK, Puscasu VA, Yoon CJ, Langer R, et al. (2012) Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano 6: 4279-4287. doi:10.1021/nn3008383. PubMed: 22471841.
19. Rhule JT, Hill CL, Judd DA, Schinazi RF, (1998) Polyoxometalates in medicine. Chem Rev 98: 327-357. doi:10.1021/cr960396q. PubMed: 11851509.
20. Yamase T, (2005) Anti-tumor,-viral, and-bacterial activities of polyoxometalates for realizing an inorganic drug. J Mater Chem 15: 4773-4782. doi:10.1039/b504585a.
21. Hasenknopf B, (2005) Polyoxometalates: Introduction to a class of inorganic compounds and their biomedical applications. Front Biosci 10: 275-287. doi:10.2741/1527. PubMed: 15574368.
22. Pope MT, Muller A, (1991) Polyoxometalate chemistry: An old field with new dimensions in several disciplines. Angewandte Chemie (International Edition in English) 30: 34-48.
23. Hill CL, Prosser-McCartha CM, (1995) Homogeneous catalysis by transition metal oxygen anion clusters. Coord Chem Rev 143: 407-455. doi:10.1016/0010-8545(95)01141-B.
24. Selvakannan PR, Swami A, Srisathiyanarayanan D, Shirude PS, Pasricha R, et al. (2004) Synthesis of aqueous Au core-Ag shell nanoparticles using tyrosine as a pH-dependent reducing agent and assembling phase-transferred silver nanoparticles at the air-water interface. Langmuir 20: 7825-7836. doi:10.1021/la049258j. PubMed: 15323537.
25. Silverstein RB, Webster F, Kiemle D, (1967) Spectrometric identification of organic compounds. New York: John Wiley & Sons. 88 pp.
26. Iliev V, Tomova D, Bilyarska L, Tyuliev G, (2007) Influence of the size of gold nanoparticles deposited on TiO2 upon the photocatalytic destruction of oxalic acid. J Mol Cat A Chem 263: 32-38. doi:10.1016/j.molcata.2006.08.019.
27. Linsebigler AL, Lu G, Yates JT Jr, (1995) Photocatalysis on TiO2 surfaces: Principles, mechanisms, and selected results. Chem Rev 95: 735-758. doi:10.1021/cr00035a013.
28. Pearson A, Bhargava SK, Bansal V, (2011) UV-Switchable Polyoxometalate Sandwiched between TiO2 and Metal Nanoparticles for Enhanced Visible and Solar Light Photococatalysis. Langmuir 27: 9245-9252. doi:10.1021/la201655n. PubMed: 21711019.
29. Pearson A, Jani H, Kalantar-zadeh K, Bhargava SK, Bansal V, (2011) Gold Nanoparticle-Decorated Keggin Ions/TiO2 Photococatalyst for Improved Solar Light Photocatalysis. Langmuir 27: 6661-6667. doi:10.1021/la2007765. PubMed: 21534553.
30. Sanyal A, Mandal S, Sastry M, (2005) Synthesis and Assembly of Gold Nanoparticles in Quasi-Linear Lysine-Keggin-Ion Colloidal Particles. Adv Funct Mater 15: 273-280. doi:10.1002/adfm.200400107.
31. Mandal S, Selvakannan PR, Pasricha R, Sastry M, (2003) Keggin ions as UV-switchable reducing agents in the synthesis of Au core-Ag shell nanoparticles. J Am Chem Soc 125: 8440-8441. doi:10.1021/ja034972t. PubMed: 12848542.
32. Bansal V, Rautaray D, Bharde A, Ahire K, Sanyal A, et al. (2005) Fungus-mediated biosynthesis of silica and titania particles. J Mater Chem 15: 2583-2589. doi:10.1039/b503008k.
33. Joshi H, Shirude PS, Bansal V, Ganesh KN, Sastry M, (2004) Isothermal titration calorimetry studies on the binding of amino acids to gold nanoparticles. J Phys Chem B 108: 11535-11540. doi:10.1021/jp048766z.
34. Ramanathan R, Campbell JL, Soni SK, Bhargava SK, Bansal V, (2011) Cationic amino acids specific biomimetic silicification in ionic liquid: A quest to understand the formation of 3-D structures in diatoms. PLOS ONE 6: e17707. PubMed: 21408611.
35. Kong Y, Pan L, Peng J, Xue B, Lu J, et al. (2007) Preparation and antibacterial activity of nanorod-amino acid polyoxometalates. Mater Lett 61: 2393-2397. doi:10.1016/j.matlet.2006.09.023.
36. Nederberg F, Zhang Y, Tan JPK, Xu K, Wang H, et al. (2011) Biodegradable nanostructures with selective lysis of microbial membranes. Nat Chem 3: 409-414. doi:10.1038/nchem.1012. PubMed: 21505501.
37. Hancock REW, Lehrer R, (1998) Cationic peptides: A new source of antibiotics. Trends Biotechnol 16: 82-88. doi:10.1016/S0167-7799(97)01156-6. PubMed: 9487736.
38. Hancock REW, (1997) Peptide antibiotics. Lancet 349: 418-422. doi:10.1016/S0140-6736(97)80051-7. PubMed: 9033483.
39. Daima HK, Selvakannan P, Homan Z, Bhargava SK, Bansal V, (2011) Tyrosine mediated gold, silver and their alloy nanoparticles synthesis: Antibacterial activity toward gram positive and gram negative bacterial strains; 2011 International Conference on Nanoscience, Technology and Societal Implications, NSTSI11. pp. pp. 1-6.
40. Rosen BP, (1971) Basic amino acid transport in Escherichia coli. J Biol Chem 246: 3653-3662. PubMed: 4931309.
41. Flynn KJ, Syrett PJ, (1986) Utilisation of L-lysine and L-arginine by the diatom Phaeodactylum tricornutum. Mar Biol 90: 159-163. doi:10.1007/BF00569122.
42. Devés R, Boyd CAR, (1998) Transporters for cationic amino acids in animal cells: Discovery, structure, and function. Physiol Rev 78: 487-545.